KPC Pharmaceuticals (SHSE:600422) Institutional Ownership: 7.86% (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600422 KPC Pharmaceuticals Inc SHSE:600422
65 GF Score
Price ¥8.56
GF Value ¥10.02
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is KPC Pharmaceuticals Institutional Ownership?

KPC Pharmaceuticals SHSE:600422 +3.01% 65 Institutional Ownership is 7.86% as of Aug. 25, 2026. GuruFocus rates SHSE:600422 with a GF Score™ of 65/100 and a GF Value™ of ¥10.02 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, KPC Pharmaceuticals's institutional ownership is 7.86%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, KPC Pharmaceuticals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, KPC Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 0.00%.

KPC Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for KPC Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

KPC Pharmaceuticals Institutional Ownership Chart

KPC Pharmaceuticals Historical Data

The historical data trend for KPC Pharmaceuticals can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 12.17 12.18 7.94 7.95 7.95 7.92 7.92 7.87 7.85 7.86
SHSE:600422
65GF Score
KPC Pharmaceuticals Inc SHSE:600422
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

KPC Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 7.86% mean?
KPC Pharmaceuticals (SHSE:600422) has a Institutional Ownership of 7.86% as of Aug. 25, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on KPC Pharmaceuticals and its competitors.
Is KPC Pharmaceuticals' Institutional Ownership too high?
KPC Pharmaceuticals' current Institutional Ownership is 7.86%. Overall, KPC Pharmaceuticals has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does KPC Pharmaceuticals' Institutional Ownership compare to ZTS?
KPC Pharmaceuticals' Institutional Ownership of 7.86% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Drug Manufacturers company?
A good Institutional Ownership depends on the Drug Manufacturers industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on KPC Pharmaceuticals and its competitors. KPC Pharmaceuticals's current Institutional Ownership is 7.86%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KPC Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, KPC Pharmaceuticals (SHSE:600422) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥10.02, compared to a current price of ¥8.56 — trading 14.6% below its estimated fair value. The current Institutional Ownership is 7.86%. KPC Pharmaceuticals' overall GF Score™ is 65/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For KPC Pharmaceuticals (SHSE:600422), the current Institutional Ownership is 7.86% as of Aug. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is KPC Pharmaceuticals (SHSE:600422) Overvalued in 2026?

Based on GuruFocus' analysis, KPC Pharmaceuticals stock appears to be undervalued. The current stock price of ¥8.56 is trading 14.6% below its estimated GF Value™ of ¥10.02. GuruFocus considers KPC Pharmaceuticals to be Modestly Undervalued.

Key valuation signals for SHSE:600422:

  • Institutional Ownership: 7.86%
  • GF Value™: ¥10.02 vs. price of ¥8.56 (14.6% below fair value)
  • GF Score™: 65/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600422 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

KPC Pharmaceuticals Business Description

Address No. 166 Keyi Road, State New and High-Technology Development Zone, Kunming, Yunnan, CHN, 650106
KPC Pharmaceuticals Inc is a pharmaceutical company which focused on innovative natural botanical drugs in China. Its business scope covers traditional Chinese medicine, chemical medicine, and medicinal circulation. Its products include Panax notoginseng, gastrodine, artemether, and special botanical drugs.
65GF Score

Get the complete analysis for SHSE:600422

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.56
Price
¥10.02
GF Value